Salient Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,500	Closed	-$276K	–	253
2016 Q2	$276K	Buy	5,500 +744	+16%	+$37.3K	0.01%	216
2016 Q1	$254K	Buy	+4,756	New	+$254K	0.01%	216